Therapeutics companies

A venture fund investing in early-stage psychedelic-based wellness, therapeutic and pharmaceutical companies globally.

Palo Santo’s diversified investment fund is helping to increase the supply of clinically effective and accessible mental health and addiction treatment solution…

We invest in therapeutic medical devices, diagnostics, and digital health. Our focus is innovative technologies that significantly improve patient outcomes and…

Curie.Bio is a new model for venture capital in biotech. We are focused on a singular mission – helping founders launch therapeutics companies that go on to rai…

FTI Venture Partners is a biotech-focused venture capital firm that has offices in Tokyo and Boston. We find out, invest, and grow transformative early-stage co…

Cambrian Biopharma is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent i…

Investing in the future of healthcare.

4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector.

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

Identifying true innovations and building ambitious companies.

Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives.

Pappas Capital invests exclusively in the life science sector.

Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.

Investors in transformative healthcare and biotechnology companies. Trusted advisors to entrepreneurs and operators.

Pivotal Life Sciences is a global healthcare investment firm that supports companies developing high impact therapeutics to address major unmet medical needs.

Finchley Healthcare Ventures (FHCV) is a Canadian venture capital fund founded in 2022 specializing in investments within the rapidly evolving landscape of life…

Since our founding in 1976, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade.

The JDRF T1D Fund is a venture philanthropy fund whose mission is to accelerate life-changing solutions to treat, prevent, and cure type 1 diabetes (T1D) throug…

We are a venture studio leveraging Alloy’s pre-competitive drug discovery platforms. Established drug discovery, scientific, and lab resources allow entrepreneu…

We are a life science venture capital investor, delivering knowledge, network, and capital to companies.